Innere Medizin, published by SPRINGER MEDIZIN VERLAG GmBH, is a prominent journal based in Germany, dedicated to advancing the field of internal medicine. With its ISSN 2731-7080 and E-ISSN 2731-7099, the journal serves as a vital platform for researchers, clinicians, and students focusing on the latest advancements, research developments, and clinical practices in internal medicine. Although categorized in the Q4 quartile for 2023, it is positioned to provide rich content that addresses diverse issues within the field, from chronic illnesses to innovative treatment methodologies. Though currently not an open-access journal, Innere Medizin emphasizes the importance of accessibility in medical research, contributing to impactful discourse within the community. In the competitive landscape of medical publications, it aims to support scholarly communication and enhance knowledge sharing among professionals, making it a significant resource for anyone interested in internal medicine.

Biomedica is a distinguished journal published by the Instituto Nacional de Salud in Colombia, dedicated to advancing knowledge within the fields of biochemistry, genetics, molecular biology, and general medicine. Since its inception in 1981, this Open Access journal has embodied a commitment to disseminating high-quality research, ensuring free and universal access to its published works. With an impressive Scopus Ranking—273rd out of 636 in Medicine and 148th out of 221 in Biochemistry, Genetics and Molecular Biology—Biomedica holds a Q3 category in both disciplines as of 2023, reflecting its growing impact and relevance in the scientific community. The journal welcomes contributions that further our understanding and lead to advancements in healthcare and biological sciences, serving as a critical resource for researchers, professionals, and students alike. The journal operates within a continuous publication model from 2001 to 2024, enriching the academic landscape with contemporary findings and fostering collaboration within the biomedical field.

The Iranian Red Crescent Medical Journal, published by ZAMENSALAMATI PUBL CO, is a vital resource in the field of general medicine, offering a platform for researchers, professionals, and students seeking to disseminate and access significant medical findings. With an impressive Scopus ranking of #159 out of 862 in the General Medicine category, this journal represents the 81st percentile, underscoring its impact and relevance within the medical community. While its Scopus coverage is listed as discontinued since 2019, the journal continues to serve as an essential reference for innovative medical research and practices in Iran and beyond. Situated in Khorasan, Mashhad, this open-access publication encourages the sharing of knowledge while fostering advancements in medical science. Researchers and students will find it an indispensable tool for staying informed about critical developments and emerging trends in medicine.

DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, published by GEORG THIEME VERLAG KG, is a prominent journal in the field of general medicine, with a storied history dating back to 1875. With an ISSN of 0012-0472 and an E-ISSN of 1439-4413, this journal serves as a vital resource for medical professionals and researchers seeking to stay informed on the latest developments and research in medicine. As of 2023, it holds a Q4 ranking in the category of Medicine (Miscellaneous) and is positioned within the 40th percentile among its peers in general medicine, highlighting its relevance within the academic community. While not an open-access journal, DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT offers readers access to a diverse range of articles that encompass clinical studies, systematic reviews, and opinion pieces geared towards enhancing medical practice and research. Located in Stuttgart, Germany, the journal continues to contribute to the advancement of medical knowledge and serves as an indispensable tool for scholars and practitioners alike.

BIOMARKERS is a distinguished journal published by Taylor & Francis Ltd, focusing on the critical intersection of biochemistry, clinical biochemistry, and health-related toxicology. With a robust history of publication since 1996 and ongoing contributions through to 2024, the journal serves as a vital platform for researchers, professionals, and students keen on exploring innovative biomarker research that spans various domains within the life sciences. The journal is currently ranked in the Q3 quartile in key areas such as Biochemistry and Health, demonstrating its reputation in the scientific community. Although it operates under a subscription model, BIOMARKERS remains an essential resource for advancing knowledge on biomarkers in health and disease, reflecting the latest advancements and methodologies within the rapidly evolving landscape of biomedical research. Researchers looking to publish in this influential journal can expect a rigorous peer-review process aimed at ensuring the dissemination of high-quality scientific inquiry.

Health and Technology, published by SPRINGER HEIDELBERG, is a prominent journal in the interdisciplinary realms of health sciences and technology, with a particular focus on the innovative applications of technology in healthcare settings. With a robust ISSN of 2190-7188 and E-ISSN 2190-7196, the journal has been making significant contributions to the field since its inception in 2011. As of 2023, it is recognized within the Q2 category in Applied Microbiology and Biotechnology, Biomedical Engineering, and Biotechnology, alongside a Q3 ranking in Bioengineering, reflecting its ongoing relevance and impact in these dynamic fields. Its commendable Scopus rankings underscore its commitment to high-quality research, being placed favorably among peers: #86 in Biomedical Engineering and #38 in Applied Microbiology and Biotechnology. Although not currently an Open Access journal, Health and Technology offers a wealth of scholarly content that is crucial for researchers, professionals, and students seeking to explore the intersection of health and technological advancements. With a converged publication timeline extending to 2024, the journal remains a vital resource for those striving to push the boundaries of innovation in health technology.

JAMA Internal Medicine is a premier scholarly journal published by the American Medical Association, renowned for its rigorous peer-review process and commitment to advancing the field of internal medicine. With an impressive impact factor that positions it in the upper echelon of medical journals, specifically ranked at Q1 in Internal Medicine and holding a remarkable Scopus rank of #2 out of 167, the journal provides a vital platform for original research, reviews, and enlightening discussions that shape clinical practices and policies. As an accessible repository of cutting-edge findings and comprehensive analyses, JAMA Internal Medicine offers both subscription and open access options, ensuring that the latest developments in medicine are available to clinicians, researchers, and the academic community at large. With its focus spanning from 2013 to 2024 and its dedication to high-quality scholarship, the journal serves as an essential resource for those seeking to enhance their understanding of the complexities of internal medicine and improve patient care.

SLAS Discovery is a leading academic journal published by Elsevier Science Inc. that serves as a pivotal resource in the fields of Analytical Chemistry, Biochemistry, Biotechnology, and Molecular Medicine. Since its inception in 2017, the journal has become increasingly influential, attaining a Q1 ranking in Analytical Chemistry and notable Q2 rankings in the associated fields as of 2023. With an impressive Scopus rank that places it within the top percentile of its categories, SLAS Discovery highlights groundbreaking research and methodologies impacting drug discovery and development. The journal advocates for open access, ensuring that its curated content is widely available to the scientific community, fostering collaboration and innovation. Researchers, professionals, and students alike will find value in the journal's comprehensive reviews and original research articles that contribute to the advancement of scientific knowledge and applications in life sciences.

JOURNAL OF MEDICAL INTERNET RESEARCH, published by JMIR PUBLICATIONS, INC, stands as a pivotal resource in the field of Health Informatics, with an esteemed ranking of #7 out of 138 in the Scopus database, placing it in the top 95th percentile. Since its inception in 1999, this Open Access journal has been committed to disseminating high-quality, peer-reviewed research that explores the intersection of healthcare and internet technologies. With its headquarters in Toronto, Canada, the journal encompasses a broad range of topics, including eHealth, telemedicine, and mobile health innovations. The impact factor and its Q1 quartile ranking highlight the journal's significant influence and prevalence in advancing the understanding of digital health landscapes. Researchers, professionals, and students alike benefit from its valuable insights, making the JOURNAL OF MEDICAL INTERNET RESEARCH an essential tool for fostering informed practices and policy-making in the rapidly evolving domain of health informatics.

Translational Research, published by Elsevier Science Inc, stands at the forefront of the rapidly evolving fields of biochemistry, medicine, physiology, and public health. With an impressive 2023 Q1 ranking in these categories, this journal has established itself as a critical platform for disseminating innovative research that bridges the gap between laboratory findings and clinical application. The journal, which has been converging knowledge since 2006, is committed to advancing scientific understanding and improving health outcomes by publishing high-quality articles that reflect rigorous peer review and impactful findings. With its impressive Scopus rankings, including a rank of #5 in Biochemistry and #7 in Physiology, it is an essential resource for researchers, practitioners, and students dedicated to the translation of scientific breakthroughs into real-world health solutions. Transitioning to an open-access model, the journal enhances accessibility and engagement, inviting a global audience to participate in the discourse shaping the future of healthcare and disease management.